18VAC110-60-290. Labeling of batch of cannabis products.
A. Cannabis products produced as a batch shall not be adulterated.
B. Cannabis products produced as a batch shall be:
- Processed, packaged, and labeled according to the U.S. Food and Drug Administration’s Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements, 21 CFR Part 111; and
- Labeled with:
- a. The name and address of the pharmaceutical processor;
- b. The brand name of the cannabis product that was registered with the board pursuant to 18VAC110-20-285;
- c. A unique serial number that matches the product with the pharmaceutical processor batch and lot number so as to facilitate any warnings or recalls the board or pharmaceutical processor deem appropriate;
- d. The date of testing and packaging;
- e. The expiration date, which shall be six months or less from the date of packaging, unless supported by stability testing;
- f. The quantity of cannabis products contained in the batch;
- g. A terpenes profile and a list of all active ingredients, including:
- Tetrahydrocannabinol (THC);
- Tetrahydrocannabinol acid (THC-A);
- Cannabidiol (CBD); and
- Cannabidiolic acid (CBDA).
For botanical cannabis products, only the total cannabidiol (CBD) and total tetrahydrocannabinol (THC) are required;
- h. For cannabis oil products, pass or fail rating based on the laboratory’s microbiological, mycotoxins, heavy metals, residual solvents, and pesticide chemical residue analysis; and
- i. For botanical cannabis products, a pass or fail rating based on the laboratory’s microbiological, mycotoxins, heavy metals, pesticide chemical residue analysis, water activity, and moisture content, and the potency.
